When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALBO - A pharma with doubling potential ahead of pivotal pedriatic trial data
Albireo Pharma Inc.
Heading into a Q2 earnings call yesterday, Baird was looking to Albireo Pharma (NASDAQ:ALBO) to provide visibility into its PEDFIC 1 Phase 3 trial - with odevixibat in progressive familiar intrahepatic cholestasis (PFIC) - for which it recently achieved its latest patient visit of a planned 60.
More news on: Albireo Pharma, Inc., Healthcare stocks news, Notable Calls